{
    "medicine_id": "9f6ceec882ff1120fce6c9ad5b1d9bc7677b917d",
    "platform_id": "DB05477",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v MUC1 Dendritic Cell Vaccine",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in cancer tumors unspecified and ovarian cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The Dendritic Cell is an immune cell whose role is the recognition processing and presentation of foreign antigens to the T cells to initiate a primary response in the effector arm of the immune system Dendritic Cell Therapy involves the harvesting of blood cells ie monocytes or macrophages from a patient and processing them in the laboratory to produce a greater than typical Dendritic Cell concentration These cells are then given back to a patient as a vaccine in order to allow for a potent immune response to cancer",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}